111
Views
109
CrossRef citations to date
0
Altmetric
Original Article

Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo Study

, , , , &
Pages 745-754 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Gunilla Goscinski, Eva Tano, Pontus Thulin, Anna Norrby-Teglund & Jan Sjölin. (2006) Release of SpeA from Streptococcus pyogenes after exposure to penicillin: Dependency on dose and inhibition by clindamycin. Scandinavian Journal of Infectious Diseases 38:11-12, pages 983-987.
Read now
R.G. Holzheimer. (2001) Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review. Journal of Chemotherapy 13:sup4, pages 159-172.
Read now
V.O. Rotimi, N.N. Al-Sweih, J.T. Anim, K. Ahmed, T.L. Verghese & F.B. Khodakhast. (2001) Influence of In-Vivo Endotoxin Liberation on Anti-Anaerobic Antimicrobial Efficacy. Journal of Chemotherapy 13:5, pages 510-518.
Read now
V.O. Rotimi, T.L. Verghese, N. Al-Sweih, F.B. Khodakhast & K. Ahmed. (2000) Influence of Five Antianaerobic Antibiotics on Endotoxin Liberation by Gram-Negative Anaerobes. Journal of Chemotherapy 12:1, pages 40-47.
Read now
Sigrid Jauris-Heipke, Edward R. Leake, John M. Billy & Thomas F. Demaria. (1997) The Effect of Antibiotic Treatment on the Release of Endotoxin during Nontypable Haemophilus influenzae-induced Otitis Media in the Chinchilla. Acta Oto-Laryngologica 117:1, pages 109-112.
Read now

Articles from other publishers (104)

Maytham Hussein, Rafah Allobawi, Jinxin Zhao, Heidi Yu, Stephanie L. Neville, Jonathan Wilksch, Labell J. M. Wong, Mark Baker, Christopher A. McDevitt, Gauri G. Rao, Jian Li & Tony Velkov. (2023) Integrated Transcriptomic and Metabolomic Mapping Reveals the Mechanism of Action of Ceftazidime/Avibactam against Pan-Drug-Resistant Klebsiella pneumoniae . ACS Infectious Diseases 9:12, pages 2409-2422.
Crossref
Beata Zalewska-Piątek. (2023) Phage Therapy—Challenges, Opportunities and Future Prospects. Pharmaceuticals 16:12, pages 1638.
Crossref
Salma M. Bahnasawy, Paul Skorup, Katja Hanslin, Miklós Lipcsey, Lena E. Friberg & Elisabet I. Nielsen. (2023) Predicting cytokine kinetics during sepsis; a modelling framework from a porcine sepsis model with live Escherichia coli. Cytokine 169, pages 156296.
Crossref
Nico van Os, Ali Javed, Femke Broere, Albert van Dijk, Melanie D. Balhuizen, Martin van Eijk, Suzan H.M. Rooijakkers, Bart W. Bardoel, Dani A.C. Heesterbeek, Henk P. Haagsman & Edwin Veldhuizen. (2022) Novel insights in antimicrobial and immunomodulatory mechanisms of action of PepBiotics CR-163 and CR-172. Journal of Global Antimicrobial Resistance 30, pages 406-413.
Crossref
Yusak Budi Susilo, Inger Mattsby-Baltzer, Anna Arvidsson & Johanna Husmark. (2022) Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. Journal of Wound Care 31:6, pages 502-509.
Crossref
Mark G Rippon, Samantha Westgate & Alan A Rogers. (2022) Implications of endotoxins in wound healing: a narrative review. Journal of Wound Care 31:5, pages 380-392.
Crossref
Muska Miller & Mervyn Singer. (2022) Do antibiotics cause mitochondrial and immune cell dysfunction? A literature review. Journal of Antimicrobial Chemotherapy 77:5, pages 1218-1227.
Crossref
Lingye Chen, Bryan D. Kraft, Victor L. Roggli, Zachary R. Healy, Christopher W. Woods, Ephraim L. Tsalik, Geoffrey S. Ginsburg, David M. Murdoch, Hagir B. Suliman, Claude A. Piantadosi & Karen E. Welty-Wolf. (2021) Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia . American Journal of Physiology-Lung Cellular and Molecular Physiology 321:2, pages L321-L335.
Crossref
Paul Skorup, Lisa Maudsdotter, Miklós Lipcsey, Anders Larsson & Jan Sjölin. (2020) Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model. Critical Care 24:1.
Crossref
Anders Thorsted, Eva Tano, Kia Kaivonen, Jan Sjölin, Lena E. Friberg & Elisabet I. Nielsen. (2020) Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime. Antimicrobial Agents and Chemotherapy 64:4.
Crossref
Saba Mokhtari, Amir Hossein Mahdavi, Mehdi Hajian, Rasoul Kowsar, Shiva Rouhollahi Varnosfaderani & Mohammad Hossein Nasr-Esfahani. (2020) The attenuation of the toxic effects of LPS on mouse pre-implantation development by alpha-lipoic acid. Theriogenology 143, pages 139-147.
Crossref
Paul SkorupLisa MaudsdotterEva TanoMiklós LipcseyMarkus CastegrenAnders LarssonJan Sjölin. (2018) Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model. Critical Care Medicine 46:7, pages e634-e641.
Crossref
Andrea J Wolf, George Y Liu & David M Underhill. (2017) Inflammatory properties of antibiotic-treated bacteria. Journal of Leukocyte Biology 101:1, pages 127-134.
Crossref
Janusz Boratyński & Bożena Szermer-Olearnik. 2017. Microbial Toxins. Microbial Toxins 107 112 .
Dae‐Won Sim, Ji‐Hun Kim, Hye‐Yeon Kim, Jung‐Hwa Jang, Woo Cheol Lee, Eun‐Hee Kim, Pyo‐Jam Park, Kwang‐Ho Lee & Hyung‐Sik Won. (2016) Structural identification of the lipopolysaccharide‐binding capability of a cupin‐family protein from Helicobacter pylori . FEBS Letters 590:17, pages 2997-3004.
Crossref
Bożena Szermer-Olearnik & Janusz Boratyński. (2015) Removal of Endotoxins from Bacteriophage Preparations by Extraction with Organic Solvents. PLOS ONE 10:3, pages e0122672.
Crossref
J.C. Plaizier, S. Li, M. Le Sciellour, B.L. Schurmann, P. Górka & G.B. Penner. (2014) Effects of duration of moderate increases in grain feeding on endotoxins in the digestive tract and acute phase proteins in peripheral blood of yearling calves. Journal of Dairy Science 97:11, pages 7076-7084.
Crossref
Lisa F Stinson, Demelza J Ireland, Matthew W Kemp, Matthew S Payne, Sarah J Stock, John P Newnham & Jeffrey A Keelan. (2014) Effects of cytokine-suppressive anti-inflammatory drugs on inflammatory activation in ex vivo human and ovine fetal membranes. REPRODUCTION 147:3, pages 313-320.
Crossref
F. Mignon, M. Piagnerelli, M. Van Nuffelen & J. L. Vincent. (2014) Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients. Infection.
Crossref
Shifeng Wang, Qingke Kong & Roy CurtissIIIIII. (2013) New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microbial Pathogenesis 58, pages 17-28.
Crossref
Zsuzsanna Gyorfy, Erno Duda & Csaba Vizler. (2013) Interactions between LPS moieties and macrophage pattern recognition receptors. Veterinary Immunology and Immunopathology 152:1-2, pages 28-36.
Crossref
Hui Deng, Urmila Maitra, Matt Morris & Liwu Li. (2013) Molecular Mechanism Responsible for the Priming of Macrophage Activation. Journal of Biological Chemistry 288:6, pages 3897-3906.
Crossref
Nicolas Schlegel, Rhea Leweke, Michael Meir, Christoph-Thomas Germer & Jens Waschke. (2012) Role of NF-κB activation in LPS-induced endothelial barrier breakdown. Histochemistry and Cell Biology 138:4, pages 627-641.
Crossref
Urmila Maitra, Hui Deng, Trevor Glaros, Bianca Baker, Daniel G. S. Capelluto, Zihai Li & Liwu Li. (2012) Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by Lipopolysaccharide. The Journal of Immunology 189:2, pages 1014-1023.
Crossref
J.A. Keelan. (2011) Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth. Journal of Reproductive Immunology 88:2, pages 176-184.
Crossref
H. K. F. van Saene, N. J. Reilly, A. de Silvestre & F. Rios. 2012. Infection Control in the Intensive Care Unit. Infection Control in the Intensive Care Unit 173 187 .
Kathryn T. Chen, Madhu S. MaloAngela K. MossSkye Zeller, Paul Johnson, Farzad EbrahimiGolam MostafaSayeda N. AlamSundaram RamasamyH. Shaw Warren, Elizabeth L. Hohmann & Richard A. Hodin. (2010) Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. American Journal of Physiology-Gastrointestinal and Liver Physiology 299:2, pages G467-G475.
Crossref
Anna Piterina, Aidan Cloonan, Claire Meaney, Laura Davis, Anthony Callanan, Michael Walsh & Tim McGloughlin. (2009) ECM-Based Materials in Cardiovascular Applications: Inherent Healing Potential and Augmentation of Native Regenerative Processes. International Journal of Molecular Sciences 10:10, pages 4375-4417.
Crossref
Jinghua Liu, Shanchao Zhao, Jing Tang, Zhijie Li, Tianyu Zhong, Yawei Liu, Dengyu Chen, Mingzhe Zhao, Yusheng Li, Xiaowei Gong, Peng Deng, Jiang H. Wang & Yong Jiang. (2009) Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-κB. FEBS Journal 276:16, pages 4598-4606.
Crossref
Nicolas Schlegel, Yvonne Baumer, Detlev Drenckhahn & Jens Waschke. (2009) Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro*. Critical Care Medicine 37:5, pages 1735-1743.
Crossref
Ping Gong, Daniel J. Angelini, Shiqi Yang, Guanjun Xia, Alan S. Cross, Dean Mann, Douglas D. Bannerman, Stefanie N. Vogel & Simeon E. Goldblum. (2008) TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia. Journal of Biological Chemistry 283:19, pages 13437-13449.
Crossref
Jason L. Herlong, Ken Reubish, H. Lee HigdonIIIIII & William R. Boone. (2008) Quantitative and qualitative analysis of microorganisms in an assisted reproductive technology facility. Fertility and Sterility 89:4, pages 847-853.
Crossref
Tie Liu, Rolf König, Jian Sha, Stacy L. Agar, Chien-Te K. Tseng, Gary R. Klimpel & Ashok K. Chopra. (2008) Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: Potential use as live-attenuated vaccines. Microbial Pathogenesis 44:3, pages 224-237.
Crossref
Masaru Nagato, Kenso Iwamoto, Nobuya Harayama, Teruo Iwata, Shun-ichi Nihei, Takahisa Tanikawa, Keiji Aibara & Masayuki Kamochi. (2008) . Nihon Shuchu Chiryo Igakukai zasshi 15:4, pages 521-525.
Crossref
G. Goscinski, E. Tano, E. Löwdin & J. Sjölin. (2007) Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose. Journal of Antimicrobial Chemotherapy 60:2, pages 328-333.
Crossref
Jacqueline Buijs, Anthonius S. M. Dofferhoff, Johan W. Mouton & Jos W. M. van der Meer. (2007) Continuous administration of PBP-2- and PBP-3-specific β-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. Journal of Antimicrobial Chemotherapy 59:5, pages 926-933.
Crossref
Daniel P. Healy, Jason C. Gardner, Barbara K. Puthoff, Richard J. Kagan & Alice N. Neely. (2007) Antibiotic-mediated bacterial filamentation: A potentially important laboratory phenomenon. Clinical Microbiology Newsletter 29:3, pages 22-24.
Crossref
J. Buijs, A.S.M. Dofferhoff, J.W. Mouton & J.W.M. van der Meer. (2006) Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice. Clinical Microbiology and Infection 12:11, pages 1105-1111.
Crossref
Rachel P. Atherton & M. Furr. (2006) Endotoxin release after antimicrobial treatment in sick foals is mediated by antimicrobial class. Journal of Equine Veterinary Science 26:8, pages 356-363.
Crossref
Takeaki Matsuda, Tracy A. Freeman, David W. Hilbert, Michael Duff, Michele Fuortes, Philip P. Stapleton & John M. Daly. (2005) Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137:6, pages 639-646.
Crossref
Roland Nau & Helmut Eiffert. (2005) Minimizing the release of proinflammatory and toxic bacterial products within the host: A promising approach to improve outcome in life-threatening infections. FEMS Immunology & Medical Microbiology 44:1, pages 1-16.
Crossref
Kang Chen, Guang Wen Sun, Kim Lee Chua & Yunn-Hwen Gan. (2005) Modified Virulence of Antibiotic-Induced Burkholderia pseudomallei Filaments . Antimicrobial Agents and Chemotherapy 49:3, pages 1002-1009.
Crossref
H.K.F. van Saene, N.J. Reilly, A. de Silvestre & G. Nardi. 2005. Infection Control in the Intensive Care Unit. Infection Control in the Intensive Care Unit 231 246 .
M. Bernabeu-Wittel, A. García-Curiel, C. Pichardo, M.E. Pachón-Ibáñez, M.E. Jiménez-Mejías & J. Pachón. (2004) Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii. Clinical Microbiology and Infection 10:10, pages 931-934.
Crossref
C. A. Gogos, A. Skoutelis, A. Lekkou, E. Drosou, I. Starakis, M. N. Marangos & H. P. Bassaris. (2004) Comparative Effects of Ciprofloxacin and Ceftazidime on Cytokine Production in Patients with Severe Sepsis Caused by Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy 48:8, pages 2793-2798.
Crossref
Wei Cui, Mei-Guey Lei, Richard Silverstein & David C. Morrison. (2016) Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria. Journal of Endotoxin Research 9:4, pages 225-236.
Crossref
Takeaki Matsuda, Hideaki Saito, Kazuhiko Fukatsu, Ilsoo Han, Tomomi Inoue, Satoshi Furukawa, Shigeo Ikeda, Akio Hidemura & Woodae Kang. (2002) Differences in Neutrophil Death Among ??-Lactam Antibiotics After In Vitro Killing of Bacteria. Shock 18:1, pages 69-74.
Crossref
Adrienne P. Bentley, Michelle H. Barton, Margie D. Lee, Natalie A. Norton & James N. Moore. (2002) Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals. American Journal of Veterinary Research 63:5, pages 660-668.
Crossref
Massimiliano Galdiero, Mariateresa Vitiello, Emma Sanzari, Marina D’Isanto, Annalisa Tortora, Anna Longanella & Stefania Galdiero. (2002) Porins from Salmonella enterica Serovar Typhimurium Activate the Transcription Factors Activating Protein 1 and NF-κB through the Raf-1-Mitogen-Activated Protein Kinase Cascade . Infection and Immunity 70:2, pages 558-568.
Crossref
Bernardo Maskin, Patricia A. Fontán, Emma G. Spinedi, Daniel Gammella & Adelina Badolati. (2002) Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia. Critical Care Medicine 30:2, pages 349-354.
Crossref
Roland Nau & Helmut Eiffert. (2002) Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis. Clinical Microbiology Reviews 15:1, pages 95-110.
Crossref
Gil Ben‐Menachem, Tomas Byström, Hagai Rechnitzer, Shlomo Rottem, Leif Rilfors & Göran Lindblom. (2001) The physico‐chemical characteristics of the phosphocholine‐containing glycoglycerolipid MfGL‐II govern the permeability properties of Mycoplasma fermentans . European Journal of Biochemistry 268:13, pages 3694-3701.
Crossref
Steve Nelson, Carol M. Mason, Ping Zhang, Warren R. Summer & Gregory J. Bagby. 2001. Critical Care Infectious Diseases Textbook. Critical Care Infectious Diseases Textbook 225 243 .
Chukwuemeka S. Okereke. (2000) Advances in the use of carbapenem antibiotics in the management of serious bacterial infections in special patient populations. I: Safety and efficacy in children and elderly patients. Current Therapeutic Research 61:5, pages 289-320.
Crossref
Michael LuchiDavid C. Morrison, Steven Opal, Ken Yoneda, Gus Slotman, Henry Chambers, Harold Wiesenfeld, Jon Lemke, John L. Ryan, David Horn & Urosepsis Study Group. (2016) A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis. Journal of Endotoxin Research 6:1, pages 25-31.
Crossref
J. SjöUlin, G. Goscinski, M. Lundholm, J. Bring & I. Odenholt. (2000) Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release. Clinical Microbiology and Infection 6:2, pages 74-81.
Crossref
Toshinobu Horii, Taku Kimura, Masayuki Nadai & Miya Kobayashi. (2000) Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo. International Journal of Infectious Diseases 4:3, pages 118-122.
Crossref
Alexander Shnyra, Michael Luchi, Jiangjun Gao, Christopher J. Papasian, David L. Horn, Richard Silverstein & David C. Morrison. 2000. Multiple Organ Failure. Multiple Organ Failure 114 130 .
Erika J. ErnstSatoru HashimotoJoseph Guglielmo, Teiji Sawa, Jean-Francois Pittet, Helmut Kropp, Jesse J. Jackson & Jeanine P. Wiener-Kronish. (1999) Effects of Antibiotic Therapy on Pseudomonas aeruginosa -Induced Lung Injury in a Rat Model . Antimicrobial Agents and Chemotherapy 43:10, pages 2389-2394.
Crossref
David C. Morrison, Richard Silverstein, Michael Luchi & Alexander Shnyra. (1999) STRUCTURE-FUNCTION RELATIONSHIPS OF BACTERIAL ENDOTOXINS. Infectious Disease Clinics of North America 13:2, pages 313-340.
Crossref
Kenji Kishi, Kazuhiro Hirai, Kazufumi Hiramatsu, Tohru Yamasaki & Masaru Nasu. (1999) Clindamycin Suppresses Endotoxin Released by Ceftazidime-Treated Escherichia coli O55:B5 and Subsequent Production of Tumor Necrosis Factor Alpha and Interleukin-1β . Antimicrobial Agents and Chemotherapy 43:3, pages 616-622.
Crossref
F. Trostdorf, R. R. Reinert, H. Schmidt, T. Nichterlein, K. Stuertz, M. Schmitz-Salue, I. Sadowski, W. Brück & R. Nau. (1999) Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis. Journal of Antimicrobial Chemotherapy 43:1, pages 87-94.
Crossref
P. van Langevelde, J. T. van Dissel, E. Ravensbergen, B. J. Appelmelk, I. A. Schrijver & P. H. P. Groeneveld. (1998) Antibiotic-Induced Release of Lipoteichoic Acid and Peptidoglycan from Staphylococcus aureus : Quantitative Measurements and Biological Reactivities . Antimicrobial Agents and Chemotherapy 42:12, pages 3073-3078.
Crossref
Hongwei Zhang, David W. Niesel, Johnny W. Peterson & Gary R. Klimpel. (1998) Lipoprotein Release by Bacteria: Potential Factor in Bacterial Pathogenesis. Infection and Immunity 66:11, pages 5196-5201.
Crossref
Toshinobu Horii, Miya Kobayashi, Masayuki Nadai, Satoshi Ichiyama & Michio Ohta. (1998) Carbapenem-induced endotoxin release in Gram-negative bacterial sepsis rat models. FEMS Immunology & Medical Microbiology 21:4, pages 297-302.
Crossref
Ai-hua Liang, Naohito Ohno & Toshiro Yadomae. (1998) Egg white lysozyme inhibits ceftazidime-induced endotoxin release and filamentation ofEscherichia coli O111:B4. Drug Development Research 44:2-3, pages 70-79.
Crossref
Ai-hua Liang, Naoto Sugawara, Naohito Ohno, Yoshiyuki Adachi & Toshiro Yadomae. (1998) Effect of O-antigenic polysaccharide of Escherichia coli on endotoxin neutralizing activity of lysozyme . FEMS Immunology & Medical Microbiology 21:1, pages 79-87.
Crossref
Steffen Oesser, Claas Schulze & Jürgen Seifert. (2014) Protective capacity of a IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Research in Experimental Medicine 198:6, pages 325-339.
Crossref
Petra van Langevelde, Kitty M. C. Kwappenberg, Paul H. P. Groeneveld, Herman Mattie & Jaap T. van Dissel. (1998) Antibiotic-Induced Lipopolysaccharide (LPS) Release from Salmonella typhi : Delay between Killing by Ceftazidime and Imipenem and Release of LPS . Antimicrobial Agents and Chemotherapy 42:4, pages 739-743.
Crossref
William R. Byrne, Susan L. Welkos, M. Louise Pitt, Kelly J. Davis, Ralf P. Brueckner, John W. Ezzell, Gene O. Nelson, Joseph R. Vaccaro, Luann C. Battersby & Arthur M. Friedlander. (1998) Antibiotic Treatment of Experimental Pneumonic Plague in Mice. Antimicrobial Agents and Chemotherapy 42:3, pages 675-681.
Crossref
R. G. Holzheimer. (1998) The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release?. Infection 26:2, pages 77-84.
Crossref
D.P. Healy, C.E. Clendening, A.N. Neely & I.A. Holder. (2016) Antibiotic-induced endotoxin release is organism-dependent in experimental Gram-negative sepsis. Journal of Endotoxin Research 4:5, pages 315-323.
Crossref
K TakahashiK NaritaY KatoT SugiyamaN KoideT YoshidaT Yokochi. (1997) Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem. Antimicrobial Agents and Chemotherapy 41:10, pages 2295-2296.
Crossref
Teruo Kirikae, Masayasu Nakano & David C. Morrison. (2013) Antibiotic‐Induced Endotoxin Release from Bacteria and Its Clinical Significance. Microbiology and Immunology 41:4, pages 285-294.
Crossref
Kayou NARITA, Naoki KOIDE, Akiko MORIKAWA, Yutaka KATO, Tsuyoshi SUGIYAMA, Tomoaki YOSHIDA & Takashi YOKOCHI. (1997) DIFFERENTIAL RELEASE OF ENDOTOXIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH ^|^beta;-LACTAM ANTIBIOTICS AND ITS EFFECT ON THE LETHAL ACTIVITY. Japanese Journal of Medical Science and Biology 50:6, pages 233-239.
Crossref
Hiroyoshi Sawada, Tomoko Toi-Matsuda, Yasushi Takeda, Hirobumi Sawai, Masaro Tashima & Minoru Okuma. (1997) Low Levels of Free Endotoxin Result from Carbapenem Treatment of Gram-Negative Bacteria. Journal of Infection and Chemotherapy 3:1, pages 27-32.
Crossref
T Yokochi, A Kusumi, N Kido, Y Kato, T Sugiyama, N Koide, G Z Jiang, K Narita & K Takahashi. (1996) Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide. Antimicrobial Agents and Chemotherapy 40:10, pages 2410-2412.
Crossref
Willem N.M. Hustinx, Barry J. Benaissa-Trouw, Ingeborg van der Tweel, Theo Harmsen, Jan Verhoef, Andy I.M. Hoepelman & Kees A. Kraaijeveld. (1996) In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentration. International Journal of Antimicrobial Agents 7:3, pages 171-179.
Crossref
Jan M. Prins. (2016) Antibiotic induced release of endotoxin - clinical data and human studies. Journal of Endotoxin Research 3:3, pages 269-273.
Crossref
R.G. Holzheimer, J.F. Hirte, B. Reith, W. Engelhardt, K.H. Horak, R. Leppert, A. Aasen, P. Capel, R. Urbaschek, H. Karch & A. Thiede. (2016) Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. Journal of Endotoxin Research 3:3, pages 261-267.
Crossref
C.N. Mock, G.J. Jurkovich, D. Dries & R.V. Maier. (2016) The clinical significance of endotoxin released by antibiotics: what is the evidence?. Journal of Endotoxin Research 3:3, pages 253-259.
Crossref
S.M. Opal, D.L. Horn, J.E. Palardy, N. Parejo, J. Jhung, A. Bhattacharjee & L.D. Young. (2016) The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis. Journal of Endotoxin Research 3:3, pages 245-252.
Crossref
Daniel P. Healy, Cynthia L. Verst-Brasch, Chris E. Clendening, Alice N. Neely & Ian Alan Holder. (2016) Influence of drug class and dose size on antibiotic-induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody. Journal of Endotoxin Research 3:3, pages 219-227.
Crossref
Jesse J. Jackson & Helmut Kropp. (2016) Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. Journal of Endotoxin Research 3:3, pages 201-218.
Crossref
Anthonius S.M. Dofferhoff & Jacqueline Buys. (2016) The influence of antibiotic-induced filament formation on the release of endotoxin from Gram-negative bacteria. Journal of Endotoxin Research 3:3, pages 187-194.
Crossref
Moshe Arditi, Jin Zhou & Sheng He Huang. (2016) Antibiotic induced bacterial killing activates vascular endothelial cells and whole blood cells. Journal of Endotoxin Research 3:3, pages 179-185.
Crossref
Daniel P. Healy, Cynthia L. Verst-Brasch, Chris E. Clendening, Alice N. Neely & Ian Alan Holder. (2016) Kinetics of endotoxin and interleukin-6 following multiple doses of antibiotics for experimental Gram-negative bacterial sepsis. Journal of Endotoxin Research 3:2, pages 93-101.
Crossref
H FrasaB Benaissa-TrouwL TavaresK van KesselW HustinxJ SchellekensK KraaijeveldJ Verhoef. (1996) Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5. Antimicrobial Agents and Chemotherapy 40:4, pages 999-1004.
Crossref
Y LinW J LeachW S Ammons. (1996) Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis. Antimicrobial Agents and Chemotherapy 40:1, pages 65-69.
Crossref
K C Lamp, M J Rybak, B J McGrath & K K Summers. (1996) Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 40:1, pages 247-252.
Crossref
Angelika Böhme, L. Bergmann, D. Hoelzer, G. Just-Nübling, P. M. Shah & W. Stille. (1995) A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patientsRandomisierte Studie mit Imipenem versus Cefotaxim/Piperacillin in der Initialtherapie von Infektionen granulozytopenischer Patienten. Infection 23:6, pages 349-355.
Crossref
Petham Muthuswamy, Tzyy-Chyn Hu, Ben Carasso, Maria Antonio & Nagamani Dandamudi. (1995) Prednisone as Adjunctive Therapy in the Management of Pulmonary Tuberculosis. Chest 107:6, pages 1621-1630.
Crossref
J M PrinsE J KuijperM L MevissenP SpeelmanS J van Deventer. (1995) Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infection and Immunity 63:6, pages 2236-2242.
Crossref
William J. ChristOsamu AsanoAndrea L. C. RobidouxMichel PerezYuan WangGloria R. DubucWendy E. GavinLynn D. HawkinsPamela D. McGuinnessMaureen A. MullarkeyMichael D. LewisYoshito KishiTsutomu KawataJohn R. BristolJeffrey R. RoseDaniel P. RossignolSeiichi Kobayashileharu HishinumaAkifumi KimuraNaoki AsakawaKouichi Katayamalsao Yamatsu. (1995) E5531, a Pure Endotoxin Antagonist of High Potency. Science 268:5207, pages 80-83.
Crossref
A.S.M. Dofferhoff, H. Potthoff, V.J.J. Bom, H.L. Bartels, H.G. de Vries-Hospers, J. Bijzet, J. Weits, W. Buurman & R.P. Bleichrodt. (2016) The release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental Gram-negative sepsis. Journal of Endotoxin Research 2:1, pages 37-44.
Crossref
A. S. M. Dofferhoff & J. Buys. 1995. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine 465 472 .
D. H. Wittmann. 1995. Immunology and Its Impact on Infections in Surgery. Immunology and Its Impact on Infections in Surgery 217 223 .
T.J. Novitsky. (2016) Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. Journal of Endotoxin Research 1:4, pages 253-263.
Crossref
M C LeesonY FujiharaD C Morrison. (1994) Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infection and Immunity 62:11, pages 4975-4980.
Crossref
J M PrinsS J van DeventerE J KuijperP Speelman. (1994) Clinical relevance of antibiotic-induced endotoxin release. Antimicrobial Agents and Chemotherapy 38:6, pages 1211-1218.
Crossref
J MohlerB FantinJ L MainardiC Carbon. (1994) Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 38:5, pages 1017-1022.
Crossref
D. Nitsche, C. Schulze, S. Oesser, A. Dalhoff & M. Sack. 1994. Ciprofloxacin i.v.. Ciprofloxacin i.v. 21 38 .
Monica Lundholm & Bertil Grönqvist. (1994) Microbiological treatment of recirculating wastewater from cleaning rolls in a rolling mill. American Journal of Industrial Medicine 25:1, pages 125-127.
Crossref
John C. RotschaferRichard A. ZabinskiKarla J. WalkerKyle Vance‐Bryan. (2013) Clinical Therapeutic Conference. The Journal of Clinical Pharmacology 32:12, pages 1083-1088.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.